Compound ID | 856
Synonym(s): BC3205 | BC 3205
Class: Pleuromutilin
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against Gram-positives causing skin and skin structure infections and Gram-negatives causing community-acquired respiratory tract infections |
| Institute where first reported: | Nabriva Therapeutics, Austria |
| Year first mentioned: | 2009 |
| Highest development stage: | Phase 1 |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/44205184 |
| Guide to Pharmacology: | BC-3205 |
| Citations: |
|